| Stage | JNJ | % of rev | KVUE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $25.4B | 100.00% | $3.9B | 100.00% | JNJ ×6.54 |
| Gross profit | $17.3B | 68.12% | $2.3B | 59.55% | JNJ +8.6pp |
| Operating income | $5.8B | 23.01% | $706M | 18.17% | JNJ +4.8pp |
| Pre-tax income | $34M | 0.13% | $609M | 15.67% | KVUE +15.5pp |
| Net income | $210M | 0.83% | $430M | 11.07% | KVUE +10.2pp |
| Stage | JNJ | KVUE | Gap · A − B |
|---|---|---|---|
| Revenue | $25.4B100.00% | $3.9B100.00% | JNJ ×6.54 |
| Gross profit | 68.12%$17.3B | 59.55%$2.3B | JNJ +8.6pp |
| Operating income | 23.01%$5.8B | 18.17%$706M | JNJ +4.8pp |
| Pre-tax income | 0.13%$34M | 15.67%$609M | KVUE +15.5pp |
| Net income |
| 0.83%$210M |
| 11.07%$430M |
| KVUE +10.2pp |
No disclosed counterparties: KVUE.
None